Furegrelate, a thromboxane synthase inhibitor, blunts the development of pulmonary arterial hypertension in neonatal piglets

The development of pulmonary arterial hypertension (PAH) in pediatric patients has been linked to the production of the arachidonic acid metabolite, thromboxane A(2) (TxA(2)). The present study evaluated the therapeutic effect of furegrelate sodium, a thromboxane synthase inhibitor, on the developme...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Hirenallur-S., Dinesh K., Detweiler, Neil D., Haworth, Steven T., Leming, Jeaninne T., Gordon, John B., Rusch, Nancy J.
Format: Artigo
Jezik:Inglês
Izdano: Medknow Publications & Media Pvt Ltd 2012
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3401873/
https://ncbi.nlm.nih.gov/pubmed/22837860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2045-8932.97605
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki